Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review
- PMID: 31508669
- DOI: 10.5935/0004-2749.20190097
Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review
Abstract
This systematic review aimed to assess the effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes in Universidade Federal de Alagoas (PROSPERO 2018 CRD42018089933). Online databases were searched (LILACS, EMBASE, MEDLINE, and CENTRAL) from inception to April 2018; references from included papers were also searched. The following keywords were used: lubricants OR artificial tears OR artificial tears, lubricants AND dry eye OR dry eye syndrome OR syndromes, dry eye OR dry eyes. Among the 2028 electronic search results, 29 full papers were retrieved and four were considered relevant. The number of participants from these studies ranged from 15 to 76. Meta-analysis was possible for the following outcomes: score of symptoms according to the Ocular Surface Disease Index - Allergan (OSDI), tear secretion rate using the Schirmer test, tear evaporation rate using the tear film breakup time test, burning, foreign body sensation, and photophobia. No statistically significant difference was observed between the two groups, and no side effects were attributed to the interventions. Evidence proving that preservative-free artificial tears are more effective than preserved artificial tears is lacking.
Similar articles
-
Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.BMC Ophthalmol. 2016 Sep 20;16(1):164. doi: 10.1186/s12886-016-0343-9. BMC Ophthalmol. 2016. PMID: 27645318 Free PMC article. Clinical Trial.
-
Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.Invest Ophthalmol Vis Sci. 2014 Jul 3;55(8):5081-9. doi: 10.1167/iovs.14-14483. Invest Ophthalmol Vis Sci. 2014. PMID: 24994869 Clinical Trial.
-
[Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study].J Fr Ophtalmol. 2018 Mar;41(3):238-245. doi: 10.1016/j.jfo.2017.05.025. Epub 2018 Mar 21. J Fr Ophtalmol. 2018. PMID: 29573863 Clinical Trial. French.
-
A Critical Appraisal of the Physicochemical Properties and Biological Effects of Artificial Tear Ingredients and Formulations.Int J Mol Sci. 2023 Feb 1;24(3):2758. doi: 10.3390/ijms24032758. Int J Mol Sci. 2023. PMID: 36769079 Free PMC article. Review.
-
Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials.Medicine (Baltimore). 2017 Sep;96(39):e8174. doi: 10.1097/MD.0000000000008174. Medicine (Baltimore). 2017. PMID: 28953672 Free PMC article. Review.
Cited by
-
Efficacy and safety of perfluorohexyloctane (PFHO) in patients with dry eye disease (DED) due to meibomian gland dysfunction (MGD): Systematic review and meta-analysis.Medicine (Baltimore). 2025 Jul 18;104(29):e43026. doi: 10.1097/MD.0000000000043026. Medicine (Baltimore). 2025. PMID: 40696694 Free PMC article.
-
New advances in medical management of dry eye: optimizing treatment strategies for enhanced relief.Int Ophthalmol. 2024 Feb 9;44(1):49. doi: 10.1007/s10792-024-02978-1. Int Ophthalmol. 2024. PMID: 38337030 Review.
-
APX‑115A, a pan‑NADPH oxidase inhibitor, reduces the degree and incidence rate of dry eye in the STZ‑induced diabetic rat model.Exp Ther Med. 2023 Mar 17;25(5):194. doi: 10.3892/etm.2023.11893. eCollection 2023 May. Exp Ther Med. 2023. PMID: 37090081 Free PMC article.
-
Can the choice of artificial tears harm patients? A narrative review with an overview of the Nordic market.Acta Ophthalmol. 2025 Aug;103(5):586-608. doi: 10.1111/aos.17455. Epub 2025 Feb 8. Acta Ophthalmol. 2025. PMID: 39921541 Free PMC article. Review.
-
Comparative antioxidant activity of various ophthalmic product types for artificial tears under different experimental conditions.Exp Ther Med. 2022 May;23(5):330. doi: 10.3892/etm.2022.11259. Epub 2022 Mar 15. Exp Ther Med. 2022. PMID: 35401809 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous